|
CAR T-cell therapy and bispecific antibodies in the management of multiple myeloma.
Hematology Am Soc Hematol Educ Program
Dima D, Banerjee R, Hansen DK.
PMID: 41348052 [PubMed - indexed for MEDLINE]
|
|
Anticoagulants in hematologic malignancies: what is the data?
Hematology Am Soc Hematol Educ Program
Alyamany R, Houghton DE.
PMID: 41348050 [PubMed - indexed for MEDLINE]
|
|
Diagnosis and management of cold agglutinin disease.
Hematology Am Soc Hematol Educ Program
Berentsen S.
PMID: 41348049 [PubMed - indexed for MEDLINE]
|
|
Peri-transplant conundrums: optimizing maintenance therapy using MRD-directed approaches.
Hematology Am Soc Hematol Educ Program
Raychaudhuri S, Cassaday RD, Percival MM.
PMID: 41348047 [PubMed - indexed for MEDLINE]
|
|
Emerging genomic biomarkers in diagnosis and classification of T-cell acute lymphoblastic leukemia.
Hematology Am Soc Hematol Educ Program
Xu J, Teachey DT.
PMID: 41348046 [PubMed - indexed for MEDLINE]
|
|
Updates in the management of newly diagnosed chronic lymphocytic leukemia.
Hematology Am Soc Hematol Educ Program
McClellan K, Sitlinger A.
PMID: 41348044 [PubMed - indexed for MEDLINE]
|
|
The aging hemophilia patient.
Hematology Am Soc Hematol Educ Program
Lewandowska M, Lim MY.
PMID: 41348043 [PubMed - indexed for MEDLINE]
|
|
New therapies in hemophilia: extend the half-life, mimic, or rebalance?
Hematology Am Soc Hematol Educ Program
Reding MT.
PMID: 41348042 [PubMed - indexed for MEDLINE]
|
|
Monoclonal gammopathy of renal significance from a hematologic perspective.
Hematology Am Soc Hematol Educ Program
Brailovski E, Jaffer IS, Landau HJ.
PMID: 41348041 [PubMed - indexed for MEDLINE]
|
|
Triplet regimens for all: genomically agnostic approaches to improve on HMA + VEN in AML?
Hematology Am Soc Hematol Educ Program
Nicol W, Wei AH.
PMID: 41348039 [PubMed - indexed for MEDLINE]
|
|
Tailored treatment of acute immune-mediated thrombotic thrombocytopenic purpura.
Hematology Am Soc Hematol Educ Program
Völker LA, Brinkkötter PT.
PMID: 41348038 [PubMed - indexed for MEDLINE]
|
|
The varieties of therapeutic experience: navigating treatment options for patients with PNH.
Hematology Am Soc Hematol Educ Program
Bienz M, Patriquin CJ.
PMID: 41348037 [PubMed - indexed for MEDLINE]
|
|
The role of MRD monitoring and options for CLL management in relapsed/refractory disease.
Hematology Am Soc Hematol Educ Program
Sworder B, Siddiqi T.
PMID: 41348036 [PubMed - indexed for MEDLINE]
|
|
The right patient, the right treatment: tailoring sickle cell disease care.
Hematology Am Soc Hematol Educ Program
Alan S, Desai P.
PMID: 41348034 [PubMed - indexed for MEDLINE]
|
|
Targeted triplet therapies incorporating FLT3 or IDH inhibitors: ready for prime time?
Hematology Am Soc Hematol Educ Program
Atluri H, Abaza Y, Altman JK.
PMID: 41348033 [PubMed - indexed for MEDLINE]
|
|
Can I stop my treatment, doctor? Is MRD-guided therapy ready for prime time?
Hematology Am Soc Hematol Educ Program
Derman BA.
PMID: 41348032 [PubMed - indexed for MEDLINE]
|
|
How to approach the high-risk myeloma from induction through relapse?
Hematology Am Soc Hematol Educ Program
Weisel KC, Schaefers C, Leypoldt LB.
PMID: 41348031 [PubMed - indexed for MEDLINE]
|
|
Deconstructing gene therapy in hemophilia for the clinician.
Hematology Am Soc Hematol Educ Program
Young G.
PMID: 41348030 [PubMed - indexed for MEDLINE]
|
|
When it's not Glanzmann thrombasthenia or Bernard-Soulier syndrome: diagnosing other qualitative platelet disorders.
Hematology Am Soc Hematol Educ Program
Hayward CPM, Tasneem S.
PMID: 41348029 [PubMed - indexed for MEDLINE]
|
|
Proactive management to improve outcomes of high-risk pregnancy in people with sickle cell disease.
Hematology Am Soc Hematol Educ Program
Obadina MA, Pecker LH.
PMID: 41348028 [PubMed - indexed for MEDLINE]
|
| |
|
 |
|
